These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35476182)
1. Baicalin-berberine complex nanocrystals orally promote the co-absorption of two components. Li Z; Liu Y; Wang J; Feng X; Nwafor EO; Zhang Y; Liu R; Dang W; Zhang Q; Yu C; Pi J; Liu Z Drug Deliv Transl Res; 2022 Dec; 12(12):3017-3028. PubMed ID: 35476182 [TBL] [Abstract][Full Text] [Related]
2. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine. Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733 [TBL] [Abstract][Full Text] [Related]
3. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method. Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600 [TBL] [Abstract][Full Text] [Related]
4. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size. Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239 [TBL] [Abstract][Full Text] [Related]
5. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles. Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417 [TBL] [Abstract][Full Text] [Related]
6. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability. Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466 [TBL] [Abstract][Full Text] [Related]
8. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. Jain S; Reddy VA; Arora S; Patel K Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Berberine Bioavailability between Oral and Rectal Administrations in Rats. Mori N; Oda K; Takakura H; Tanaka Y; Yokooji T; Murakami T Biol Pharm Bull; 2023; 46(11):1639-1642. PubMed ID: 37914368 [TBL] [Abstract][Full Text] [Related]
10. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. Godugu C; Patel AR; Doddapaneni R; Somagoni J; Singh M PLoS One; 2014; 9(3):e89919. PubMed ID: 24614362 [TBL] [Abstract][Full Text] [Related]
11. MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability. Wang A; Yang W; Yang X; Mei X; Hu T; Liang R; Meng D; Yan D Biomed Pharmacother; 2020 Jul; 127():110140. PubMed ID: 32380387 [TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, in vitro and in vivo studies of liposomal berberine using novel natural Fiber Interlaced Liposomal technology. Sharma VM; Valsaraj TV; Venkataramana Sudeep H; Raj A; Kodimule S; Jacob J Eur J Pharm Biopharm; 2024 Oct; 203():114431. PubMed ID: 39094668 [TBL] [Abstract][Full Text] [Related]
13. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Zhang J; Huang Y; Liu D; Gao Y; Qian S Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994 [TBL] [Abstract][Full Text] [Related]
14. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability. Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018 [TBL] [Abstract][Full Text] [Related]
15. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge. Xu HY; Liu CS; Huang CL; Chen L; Zheng YR; Huang SH; Long XY Colloids Surf B Biointerfaces; 2019 Sep; 181():927-934. PubMed ID: 31382342 [TBL] [Abstract][Full Text] [Related]
16. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation. Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189 [TBL] [Abstract][Full Text] [Related]
17. The Increased Dissolution and Oral Absorption of Itraconazole by Nanocrystals with an Endogenous Small-Molecule Surfactant as a Stabilizer. Chang S; Yang Q; Liu J; Yin L; Han J; Zong L; Pu X Molecules; 2024 Apr; 29(8):. PubMed ID: 38675589 [TBL] [Abstract][Full Text] [Related]
18. The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes. Yu Y; Tian Y; Zhang H; Jia Q; Chen X; Kang D; Du Y; Song S; Zheng A Molecules; 2022 Jan; 27(2):. PubMed ID: 35056734 [TBL] [Abstract][Full Text] [Related]
19. Novel co-crystal of 3-methylcinnamic acid with berberine (1:1): synthesis, characterization, and intestinal absorption property. He Y; Chen S; Li M; Gao Y; Feng H; Umar Q; Yin D; Feng Y Drug Dev Ind Pharm; 2023 Oct; 49(10):617-627. PubMed ID: 37725481 [TBL] [Abstract][Full Text] [Related]
20. Process optimization and evaluation of novel baicalin solid nanocrystals. Yue PF; Li Y; Wan J; Wang Y; Yang M; Zhu WF; Wang CH; Yuan HL Int J Nanomedicine; 2013; 8():2961-73. PubMed ID: 23976849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]